,trastuzumab deruxtecan
astrazeneca,daiichi sankyo
['lcsm,(-blcsm)', 'crcsm', 'bcsm', 'crc,(-ccrcc),(-tbcrc049),(-mccrcc),(-mbcrc)', 'breast', 'destiny-breast04', 'gastric']
great commentary by on destiny-breast04. 1) need more sensitive her2 expression tests ie that developed by david rimm 2) t-dxd holds promise for other tumors ie gastric #lcsm #crcsm. 3) need to understand resistance mechanisms. #asco22 #bcsm 
Mother of Warlords & Slayer of Cancers|Brst/Gyn #radonc @WeillCornell @nyphospital @nypbrooklyn | #globaloncology | #globalhealth|#MedEd|#gyncsm|#bcsm????????